Adjunctive Therapy in Acute Myocardial Infarction

R. Scott Wright, Imran S. Syed and Joseph G. Murphy

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI:

Series: Mayo Clinic Scientific Press

Adjunctive Therapy in Acute Myocardial Infarction

Show Summary Details


Adjunctive therapy for acute myocardial infarction should be initiated immediately the diagnosis is suspected—in many cases before the diagnosis confirmation or definitive reperfusion therapy is instigated. Adjunctive therapy should include the following (absent any contraindications): aspirin, oxygen, morphine, intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin, β‎-blockade (initially intravenously and then orally), and nitroglycerin (except in patients with hypotension or suspected right ventricular infarction). Each component of adjunctive therapy is reviewed in this chapter, as well as management of diabetes mellitus and the long-term use of adjunctive therapy.

Chapter.  5589 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.